The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up
The Harvard Drug Group, LLC d/b/a Major Pharmaceutical and Rugby Laboratories is initiating a voluntary recall of a single lot of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg to the consumer level. The Harvard Drug Group, LLC received a customer complaint from a dis (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 14, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Droperidol most effective sedation medication for agitation with less sides effects
(Society for Academic Emergency Medicine) In a randomized, double-blind trial of patients with acute undifferentiated agitation in the emergency department, droperidol was more effective for sedation and was associated with fewer episodes of respiratory depression than lorazepam or either dose of ziprasidone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA informa que el psicof ármaco ziprasidona (Geodon) está relacionado con reacciones cutáneas poco comunes, pero potencialmente fatales
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 3, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Characterization of intentional lurasidone ingestions using the United States National Poison Data System - Weiss SJ, Cueto-Vilorio VA, Dharmaraj R, Barolia D, Nashat A, Walsh SJ, Simpson SE.
Introduction: The ziprasidone analogue lurasidone is approved for the treatment of schizophrenia and bipolar disorder for adults and children older than 10 years. Small studies and case reports suggest lurasidone overdose is not generally associate... (Source: SafetyLit)
Source: SafetyLit - March 16, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
FDA Drug Safety Communication: FDA reporting mental health drug ziprasidone (Geodon) associated with rare but potentially fatal skin reactions
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Neither Haloperidol, Ziprasidone Shortens Delirium in ICU
No decrease in duration versus placebo for patients with hypoactive, hyperactive delirium in ICU (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 26, 2018 Category: Respiratory Medicine Tags: Neurology, Pharmacy, Psychiatry, Pulmonology, Critical Care, Journal, Source Type: news
Neither Haloperidol, Ziprasidone Shortens Delirium in ICU
THURSDAY, Oct. 25, 2018 -- For patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the intensive care unit, neither haloperidol nor ziprasidone alters the duration of delirium compared with placebo, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 25, 2018 Category: Pharmaceuticals Source Type: news
Antipsychotics Fail to Limit Delirium in ICU Patients - Study Antipsychotics Fail to Limit Delirium in ICU Patients - Study
Neither intravenous haloperidol nor ziprasidone work better than placebo to counteract delirium in patients in the intensive care unit, researchers behind a large study reported Monday.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 24, 2018 Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news
What We Know About the Effect of Psychotropic Drugs on Migrant Kids
A federal judge on Monday ruled that the government must obtain parental or guardian consent before administering psychotropic drugs—those that can affect the brain or behavior—to migrant children in its care. But plenty of questions still remain about what these drugs do to young brains in the first place.
“The benefits or risks of psychotropic medications to brain development are only beginning to be evaluated,” says Dr. Manpreet Singh, director of the Pediatric Mood Disorders Program at Stanford University. “We haven’t actually looked, directly and in systematic ways, at the effects o...
Source: TIME: Health - July 31, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Source Type: news
Geodon (Ziprasidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 12, 2016 Category: Drugs & Pharmacology Source Type: news
Understanding & Giving Support to Someone with Schizophrenia
What comes to mind when the word schizophrenia is spoken? Likely images of a bedraggled man or woman, with wild hair and tattered clothing, chatting away with someone that you can’t see, as they amble down a city street. You might actually cross the street to avoid him or her, so as not to get caught up in their delusion.
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V) describes the condition as “characterized by delusions, hallucinations, disorganized speech and behavior, and other symptoms that cause social or occupational dysfunction. For a diagnosis, symptoms must have been present for s...
Source: Psych Central - February 1, 2016 Category: Psychiatry Authors: Edie Weinstein, MSW, LSW Tags: Antipsychotics Atypical Antipsychotics Caregivers Disorders Family General Medications Psychology Psychotherapy Schizophrenia Treatment American Psychiatric Association Delusion Delusional disorder Diagnostic And Statistical Ma Source Type: news
Child & Adolescent Mental Health: A Practical, All-in-One Guide
About twenty percent of children and adolescents in the United States — that’s roughly fifteen million kids — have a diagnosable mental health condition. Odds are, you know one, or have one, yourself: a child who struggles to control their emotions and behaviors, or has a hard time in school or relating to others.
Whatever happened to our free-spirited, happy, socially adjusted, emotionally stable children and adolescents, you might ask. They still exist. But it’s a widely accepted fact in psychiatry and clinical psychotherapy that children and adolescents are dealing with an increased number of educational, socia...
Source: Psych Central - August 31, 2015 Category: Psychiatry Authors: Tamara Hill, MS Tags: Book Reviews Children and Teens Disorders Family General Parenting Professional Psychiatry Psychological Assessment Psychology Psychotherapy School Issues Students a practical all in one guide Child & Adolescent Mental Health Source Type: news
FDA Warns of Skin Reactions to Antipsychotic
(MedPage Today) -- New label for ziprasidone warns of life-threatening reaction. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 12, 2014 Category: Primary Care Source Type: news
Antipsychotic Linked to Potentially Fatal Skin Reaction (FREE)
By Amy Orciari Herman
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The antipsychotic ziprasidone (marketed as Geodon and generics) is associated with increased risk for drug reaction with eosinophilia and systemic symptoms (DRESS), the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 12, 2014 Category: Primary Care Source Type: news
FDA warns of potentially fatal skin reaction with ziprasidone
The Food and Drug Administration is warning that the atypical antipsychotic ziprasidone (Geodon) may be associated with a rare but potentially fatal skin reaction.
The agency issued the communication on Dec. 11, saying that it had...googletag.display('div-gpt-ad-cta'); (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 11, 2014 Category: Dermatology Tags: CPN FDA & CDC CPN News CPN Psychotic Disorders EM FDA and CDC EM News EM Dermatology FPN FDA Source Type: news
